Inhalation surfactant therapy in the integrated treatment of severe COVID-19 pneumonia
The objective: to evaluate the effectiveness of inhaled surfactant therapy in the integrated treatment of severe COVID-19 pneumonia in a multicenter prospective clinical trial of surfactant-BL.Subjects and methods. 122 patients with severe COVID-19-associated pneumonia treated in two treatment cente...
Main Authors: | A. E. Bautin, S. N. Avdeev, A. A. Seyliev, M. V. Shvechkova, Z. M. Merzhoeva, N. V. Trushenko, A. P. Semenov, K. B. Lapshin, O. A. Rozenberg |
---|---|
Format: | Article |
Language: | Russian |
Published: |
NEW TERRA Publishing House
2020-10-01
|
Series: | Tuberkulez i Bolezni Lëgkih |
Subjects: | |
Online Access: | https://www.tibl-journal.com/jour/article/view/1456 |
Similar Items
-
Characteristics and outcome of viral pneumonia caused by influenza and Middle East respiratory syndrome-coronavirus infections: A 4-year experience from a tertiary care center
by: Abeer M Al-Baadani, et al.
Published: (2019-01-01) -
Pneumonia a Varicella zoster Varicella zoster pneumonia
by: Carla Ferreira Santos, et al.
Published: (2010-06-01) -
Impact of Corticosteroid Administration within 7 Days of the Hospitalization for Influenza Pneumonia with Respiratory Failure: A Propensity Score Analysis Using a Nationwide Administrative Database
by: Daisuke Okuno, et al.
Published: (2021-01-01) -
BLOOD CONTENTS OF DEFENSINS IN PATIENTS WITH PNEUMONIAS CAUSED BY INFLUENZA А/H1N1
by: E. N. Romanova, et al.
Published: (2014-07-01) -
Steroids for community-acquired pneumonia? not in my house!
by: Kuberski T
Published: (2016-11-01)